Related Experiment Video
Updated: Jan 8, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
Improving Medication Adherence and Medication Optimization With a Medicaid-Funded Statewide Diabetes Quality
Elizabeth A Beverly1, Anirudh Prabu2,3, Joshua J Joseph4
1Ohio University Heritage College of Osteopathic Medicine, Athens, OH.
Clinical Diabetes : a Publication of the American Diabetes Association
|December 24, 2025
Summary
Improving medication adherence for diabetes patients on Medicaid modestly increased adherence rates by 3.4%. However, disparities persist, requiring further interventions for better glycemic control and cardiorenal outcomes.
Area of Science:
- Diabetes management
- Health disparities
- Medication adherence
Background:
- Medication adherence is a significant barrier to achieving glycemic control in Medicaid recipients with diabetes.
- Type 2 diabetes affects a substantial portion of the Medicaid population, necessitating quality improvement initiatives.
Purpose of the Study:
- To reduce the percentage of adults with type 2 diabetes and A1C >9.0% within a Medicaid patient population.
- To evaluate the impact of a 1-year intervention on medication adherence in primary care practices serving high-volume Medicaid patients.
Main Methods:
- Recruited 19 primary care practices in Ohio serving a high volume of Medicaid patients.
- Implemented a 1-year intervention aimed at improving diabetes care and medication adherence.
- Measured the mean medication possession ratio (MPR) before and after the intervention.
Main Results:
- The mean medication possession ratio (MPR) improved from 71.6% to 74.1%, a relative improvement of 3.4%.
- Factors associated with lower MPR included younger age, identifying as non-Hispanic Black or Hispanic, and pre-intervention A1C >9.0%.
Conclusions:
- The intervention showed a modest improvement in medication adherence among Medicaid recipients with diabetes.
- Addressing persistent health disparities and expanding the use of cardiorenal protective therapies are crucial for improving diabetes outcomes in this population.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
844
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
844
01:28Drug Therapy
229
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
229
01:30Health Information Technology and Healthcare Information System
3.2K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.2K
01:15Methods of Documentation VI: Case Management Model
833
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
833
01:21Drug Dosing: Obese Patients
195
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
195
01:24Dosage Regimen: Individualization
151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151